BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 18632619)

  • 1. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.
    Sehat B; Andersson S; Girnita L; Larsson O
    Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor.
    Vecchione A; Marchese A; Henry P; Rotin D; Morrione A
    Mol Cell Biol; 2003 May; 23(9):3363-72. PubMed ID: 12697834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
    Xu C; Fan CD; Wang X
    Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grb10/Nedd4-mediated multiubiquitination of the insulin-like growth factor receptor regulates receptor internalization.
    Monami G; Emiliozzi V; Morrione A
    J Cell Physiol; 2008 Aug; 216(2):426-37. PubMed ID: 18286479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.
    Smith CJ; Berry DM; McGlade CJ
    J Cell Sci; 2013 Mar; 126(Pt 6):1366-80. PubMed ID: 23418353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.
    Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Girnita A; Lefkowitz RJ; Larsson O
    J Biol Chem; 2005 Jul; 280(26):24412-9. PubMed ID: 15878855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ubiquitination of EGF receptors with C-terminal domain deletion and point mutations during endocytosis].
    Kondratov KA; Melikova MS; Chernorudskiĭ AL; Kornilova ES
    Tsitologiia; 2009; 51(7):617-23. PubMed ID: 19764654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-dependent regulation of phospho-AKT dynamics by the ubiquitin E3 ligase, NEDD4-1, in the insulin-like growth factor-1 response.
    Fan CD; Lum MA; Xu C; Black JD; Wang X
    J Biol Chem; 2013 Jan; 288(3):1674-84. PubMed ID: 23195959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.
    Chan W; Tian R; Lee YF; Sit ST; Lim L; Manser E
    J Biol Chem; 2009 Mar; 284(12):8185-94. PubMed ID: 19144635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route.
    de Melker AA; van der Horst G; Calafat J; Jansen H; Borst J
    J Cell Sci; 2001 Jun; 114(Pt 11):2167-78. PubMed ID: 11493652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
    Sévère N; Dieudonné FX; Marie PJ
    Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
    Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
    Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Cbl directs EGF receptors into an endocytic pathway that involves the ubiquitin-interacting motif of Eps15.
    de Melker AA; van der Horst G; Borst J
    J Cell Sci; 2004 Oct; 117(Pt 21):5001-12. PubMed ID: 15383614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered ubiquitin ligase PTB-U-box targets insulin/insulin-like growth factor receptor for degradation and coordinately inhibits cancer malignancy.
    Wang Q; Ru Y; Zhong D; Zhang J; Yao L; Li X
    Oncotarget; 2014 Jul; 5(13):4945-58. PubMed ID: 24970814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
    Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
    Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.
    Li H; Zhang J; Ke JR; Yu Z; Shi R; Gao SS; Li JF; Gao ZX; Ke CS; Han HX; Xu J; Leng Q; Wu GR; Li Y; Tao L; Zhang X; Sy MS; Li C
    Cell Rep; 2022 Dec; 41(12):111834. PubMed ID: 36543142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia.
    Tang J; Tu S; Lin G; Guo H; Yan C; Liu Q; Huang L; Tang N; Xiao Y; Pope RM; Rajaram MVS; Amer AO; Ahmer BM; Gunn JS; Wozniak DJ; Tao L; Coppola V; Zhang L; Langdon WY; Torrelles JB; Lipkowitz S; Zhang J
    J Exp Med; 2020 Apr; 217(4):. PubMed ID: 31999304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
    Worrall C; Suleymanova N; Crudden C; Trocoli Drakensjö I; Candrea E; Nedelcu D; Takahashi SI; Girnita L; Girnita A
    Oncogene; 2017 Jun; 36(23):3274-3286. PubMed ID: 28092675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of Lck by Cbl ubiquitin ligase.
    Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.